Trial
NCT04334915
Study to Evaluate the Effects of Cenicriviroc Mesylate on Arterial Inflammation in People Living With HIV
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators
Allergan
Condition
HIV Infections
Intervention
Cenicriviroc Mesylate (CVC)
Why stopped
Industry supporter no longer supporting the study. Protocol A5415's study will run instead.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-12-21